SCHEMBL4386284

SCHEMBL4386284

CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)CC(=O)Nc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 2/20 0.74
LTB4R Q15722 1/20 0.48
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
CNR1 P21554 3/20 0.45
POLB P06746 1/20 0.45
ATM Q13315 1/20 0.45
SOAT2 O75908 1/20 0.43
SOAT1 P35610 1/20 0.43
TUBB4A P04350 2/20 0.43
TUBB P07437 2/20 0.43
TUBA3C P0DPH7 2/20 0.43
TUBA1B P68363 2/20 0.43
TUBA4A P68366 2/20 0.43
TUBB4B P68371 2/20 0.43
TUBB3 Q13509 2/20 0.43
TUBB2A Q13885 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14429901 0.91 S1PR3 (0.64) S1PR3LTB4RL3MBTL1GAATDP1
SCHEMBL14440896 0.87 S1PR3 (0.58) S1PR3THRBL3MBTL1GAATDP1
SCHEMBL23016832 0.85 LTB4R (0.55) S1PR3LTB4RPOLB
SCHEMBL6480100 0.83 S1PR3 (0.62) S1PR3THRATHRBCNR1SOAT2
SCHEMBL14441039 0.83 S1PR3 (0.56) S1PR3LTB4RL3MBTL1GAATDP1
SCHEMBL14440895 0.83 S1PR3 (0.56) S1PR3LTB4RL3MBTL1GAATDP1
SCHEMBL14441001 0.80 S1PR3 (0.54) S1PR3LTB4RL3MBTL1GAATDP1
SCHEMBL5461336 0.80 S1PR3 (0.53) S1PR3LTB4RL3MBTL1GAATDP1
SCHEMBL5461333 0.79 L3MBTL1 (0.56) S1PR3L3MBTL1GAATDP1POLB
SCHEMBL14441040 0.79 S1PR3 (0.52) S1PR3LTB4RL3MBTL1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629400-B2 Image making medium HYMAN SYDNEY 2009-12-08 US disclosed
US-20070185176-A1 Heparanase inhibitors and uses thereof INSIGHT BIOHARMACEUTICALS LTD. (IL) 2007-08-09 US disclosed
US-20070185176-A1 Heparanase inhibitors and uses thereof INSIGHT BIOHARMACEUTICALS LTD. (IL) 2007-08-09 US disclosed
US-20070185176-A1 Heparanase inhibitors and uses thereof INSIGHT BIOHARMACEUTICALS LTD. (IL) 2007-08-09 US disclosed
US-20030035917-A1 Image making medium HYMAN SYDNEY (US) 2003-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185176-A1 Heparanase inhibitors and uses thereof HPSE, ENGASE, HEXA S1PR3 1318/4885LTB4R 1976/4885THRA 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.